QMENTA develops a cloud-native software platform designed to support imaging workflows in clinical trials and research. The company’s platform enables centralized management of MRI data, from automated upload to analysis and review. Its approach focuses on standardizing imaging operations across sites and studies to improve efficiency and data quality. QMENTA positions its technology within clinical research and trial operations rather than direct patient-facing care.

The technology automates ingestion of imaging data from multiple sites and applies AI-driven tools to extract quantitative biomarkers from MRI scans. These outputs support consistent analysis, quality control, and longitudinal assessment across large datasets. Centralized review tools enable collaboration among imaging teams, radiologists, and trial sponsors. The platform emphasizes scalability, compliance, and interoperability with existing imaging infrastructure.

QMENTA targets pharmaceutical companies, imaging core labs, and research organizations conducting neuroimaging-intensive clinical trials. The platform is intended to streamline trial execution, reduce operational complexity, and improve consistency in imaging-derived endpoints. Its focus reflects growing demand for cloud-based, AI-enabled infrastructure to support biomarker-driven drug development.